The future of medicine lies within us.
We develop one-time, off-the-shelf, in vivo treatments that precisely and durably engineer any cell of the hematopoietic system to cure diseases from within.
Ensoma’s platform revealed
We are creating a new kind of genomic medicine for patients around the world.
Our platform is the most advanced in vivo hematopoietic stem cell (HSC) engineering technology. It combines an off-the-shelf, in vivo delivery system with an advanced gene engineering toolkit. Through its HSC engineering platform, Ensoma can selectively and durably modify any cells of the entire hematopoietic system to treat diseases with unprecedented versatility – all with a one-time therapy.
A simple vision for the patient journey
The patient experience is a crucial part of treatment. We aim to shape a new experience defined by simplicity, speed and safety.
Excited by our bold vision to bring forth a new kind of medicine?
